HLX07+carboplatin+pemetrexed
HLX07-nsqNSCLC201
Phase 2 small_molecule active
Quick answer
HLX07+carboplatin+pemetrexed for HLX07, nsqNSCLC, High EGFR Expression is a Phase 2 program (small_molecule) at Shanghai Henlius Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai Henlius Biotech
- Indication
- HLX07, nsqNSCLC, High EGFR Expression
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active